Home/ Stocks/ CERS

Cerus Corp

CERS XNAS

$2.02 -0.13 (-5.92%) ▼ 15-min delayed

Open

$2.14

High

$2.14

Low

$2.01

Volume

2.07M

Market Cap

$407.95M

About Cerus Corp

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 345 Website →

Related Market News

No specific coverage for CERS yet. Check out our latest market news or earnings calendar.

Get CERS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cerus Corp.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.